A. D. da Silva

Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in Amazonas, a Brazilian setting with high levels of hybrid immunity

Kimihito Ito, G. Wallau, M. Siqueira, 2022, medRxiv.

In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19

Carolina Q. Sacramento, T. Tuschl, D. Patel, 2021, The Journal of antimicrobial chemotherapy.

Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil

F. Bozza, P. Bozza, Hui Jiang, 2021, Emerging infectious diseases.

Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells

Carolina Q. Sacramento, Alberto Paccanaro, P. Bozza, 2021, bioRxiv.